Clinical Trial

Biomarker Discovery in Lung Cancer - Malaysia

Name: Biomarker Discovery in Lung Cancer - Malaysia — clinical trial record (NCT06504927)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This study aims to 1. Identify biomarkers and signatures to differentiate between high-risk and lung cancer patients. 2. Discover blood-based biomarkers that can be used as an adjunct test to imaging diagnosis to improve patient follow-up.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2024-07-10.

Trial Details

NCT Number	NCT06504927
Lead Sponsor	University of Malaya Collaborators: MiRXES Pte Ltd
Conditions	Lung Cancer
Enrollment	400 participants
Start Date	2024-01-16
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2024-07-18